Govind Raghavan

Govind Raghavan practices at UCSF Medical Group Business Services in San Francisco, California.

Govind Raghavan's NPI, 1861951998, was assigned on March 18, 2019. Govind Raghavan graduated from David Geffen School of Medicine at UCLA in 2019. Govind Raghavan holds California license A180655.

Govind Raghavan's primary practice is UCSF Medical Group Business Services, at 3333 California St, San Francisco, CA 94118 in San Francisco County. The practice phone is (415) 353-2808.

Govind Raghavan's primary practice is UCSF Medical Group Business Services in San Francisco, California. The medical group on file is UCSF Pediatrics. Dmand AI also links Govind Raghavan to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Govind Raghavan practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Govind Raghavan's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Govind Raghavan is board certified in psychiatry by the American Board of Psychiatry and Neurology. Govind Raghavan is licensed in California.

Dmand AI lists psychoses among the conditions Govind Raghavan treats.

CMS data shows 430 Medicare services from Govind Raghavan across 3 procedure codes in 2024, for 137 Medicare patients. Medicare paid $31,769 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 137 Medicare patients who saw Govind Raghavan in 2024. The largest group is under 65, with 67 patients. 75% of them have anxiety, and 75% have mood disorders. 56% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Govind Raghavan's median patient age at 38, with 55% women.

In 2024, Govind Raghavan wrote 192 Medicare Part D claims for 31 patients. 91% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $310 in total drug cost. In 2023, CMS named 78 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Govind Raghavan for performance year 2024, reported as part of a group. Govind Raghavan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Govind Raghavan, published from 2016 to 2025. The most frequent topics are Anesthesia, Obstetrical. Govind Raghavan has published most often in J Anesth. Govind Raghavan's most frequent co-authors are Allen M. Chen, MD, Amar Upadhyaya Kishan, MD and Percy Po-Yih Lee, MD.

CMS Open Payments shows 3 general payments to Govind Raghavan from 2 drug and device companies in 2023. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $42.

Govind Raghavan graduated from David Geffen School of Medicine at UCLA in 2019. Govind Raghavan is a member of APA.

Govind Raghavan is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.